Thalidomide makes comeback as cancer drug and may combine well with heparin
Thalidomide is making a subsidized comeback in Australia to treat multiple myeloma. In the USA thalidomide is already available to treat prostate cancer. It has not been too effective on its own. Giving it in combination with other chemotherapy may increase side effects. But a team of oncologists has found that giving a blood-thinner to prevent clots from thalidomide plus taxane chemotherapy “could provide a therapeutic and survival advantage for patients….”
(full story…)